Change In PSA Level Does Not Predict Prostate Cancer
2/25/2011
Researchers at Memorial Sloan-Kettering Cancer Center have found that change in PSA levels over time known as PSA velocity is a poor predictor of prostate cancer and may lead to many unnecessary biopsies. The new study of more than 5,000 men was published online February 24 in the Journal of the National Cancer Institute...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a study published online in the American Journal of Clinical Pathology demonstrated the ability of the cobas HPV Test to individually detect HPV-16 and HPV-18, two of the highest risk HPV genotypes causing 70 percent of cervical cancer cases...
Mira Dx Licenses Triple Negative Breast Cancer Risk Variant From Yale University
2/25/2011
Mira Dx announced that it has licensed technology from Yale University based on the acceptance of a pivotal breast cancer study in the January issue of the journal Cell Cycle. While numerous BRCA1 coding sequence mutations are associated with breast cancer risk, such mutations in BRCA1 account for less than 5% of breast cancer risk...
Researchers say a new kind of tracing agent is more accurate than current methods in helping identify tumor-draining sentinel lymph nodes in breast cancer and melanoma patients. That's the finding in a new study that appears in the online version of the Annals of Surgical Oncology. "This is an important finding for both physicians, and patients," says Stanley Leong, M.D., M.S., F.A.C.S...
Multiple Childbirth Linked To Rare But Aggressive 'Triple-Negative' Breast Cancer
2/25/2011
Full-term pregnancy has long been associated with a reduced risk of breast cancer, but a new study finds that the more times a woman gives birth, the higher her risk of "triple-negative" breast cancer, a relatively uncommon but particularly aggressive subtype of the disease...
Scalp Cooling Cap May Help Chemotherapy Patients Keep Hair
2/25/2011
A feasibility study to test the use of a scalp cooling device that breast cancer patients will wear while undergoing chemotherapy treatment will be conducted at Wake Forest University Baptist Medical Center. This will be part of the first significant study of the medical device in the United States...
Guided Therapeutics, Inc. (OTCBB & OTCQB: GTHP) announced that its non-invasive and painless test for the early detection of cervical precancer, the LightTouch™, will be the subject of a presentation at The American College of Obstetricians and Gynecologists (ACOG) 59th Annual Clinical Meeting to be held April 30 - May 4, 2011 in Washington, DC...
Mice Protected From Hepatitis C Virus Using New Vaccine Technology
2/25/2011
Three percent of the world's population is currently infected by hepatitis C. The virus hides in the liver and can cause cirrhosis and liver cancer, and it's the most frequent cause of liver transplants in Denmark...
Improved Identification Of Deadly Skin Cancer By Laser
2/25/2011
High-resolution images from a laser-based tool developed at Duke University could help doctors better diagnose melanoma, the deadliest form of skin cancer, while potentially saving thousands of lives and millions of dollars in unnecessary healthcare costs each year...
Prostate cancer in men usually becomes resistant to initial hormone treatment within a few years of diagnosis (and is thereafter called castration-resistant prostate cancer) and tumours begin to grow again and spread to other parts of the body (metastasis), including bones...